Bio-Techne TECH Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Bio-Techne’s reported figures.
Based on the most recent quarter.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's price / sales?
- Bio-Techne (TECH) reported price / sales of 6.8× in Q1 2026.
- How has Bio-Techne's price / sales changed year-over-year?
- Bio-Techne's price / sales decreased by 11.9% year-over-year, from 7.7× to 6.8×.
- What is the long-term trend for Bio-Techne's price / sales?
- Over 4 years (2021 to 2025), Bio-Techne's price / sales has grown at a -23.7% compound annual growth rate (CAGR), from 19× to 6.4×.
- What does price / sales mean?
- How many dollars investors pay for each dollar of the company's annual sales.
- How do you interpret price / sales?
- Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
- How does price / sales compare across companies?
- Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.